In spite of advances in cancer diagnosis and treatment, cancer remains a serious problem for most societies. Unfortunately, it is unlikely that cancer can ever be eliminated entirely; therefore, we must continue to seek ways to reduce the incidence, morbidity, and mortality from this devastating disease. Although most cancer research is devoted to finding new treatments, there are many other obstacles to reducing death from cancer that will need to be addressed if significant progress is to be made.
One obstacle is simply the growth in the number of cancer cases owing to the increasing longevity of populations, particularly in industrialized nations. In the United States of America and Japan, there is an additional problem caused by the large cohort of people born at the end of the Second World War. This "baby boom" generation is now entering the age group in which cancers are most prevalent. The majority of cancer cases and deaths occur in people over the age of 60. As the number of people in this age group continues to increase disproportionately, the number of cancer cases in the population will increase, making it difficult to reduce the cancer burden.
Another major obstacle to reducing cancer mortality is our current inability to deal with two factors responsible for nearly 50% of cancer deaths in the United States of America. These are tobacco use and obesity, both of which are strongly influenced by human behavior and public policy. Although there are validated methods for preventing and reducing tobacco use, little attention has been paid to implementing these tobacco control programs. Similarly, little funding is devoted to research on behavioral change, which is necessary to deal with both tobacco use and the obesity epidemic.
Another significant contributor to cancer mortality is environmental carcinogens, many of which are by-products of human activities. It is estimated that about 15% of cancers worldwide result from exposure to environmental carcinogens. Again, very little of the funding for cancer research is devoted to identifying such agents and preventing exposure to them, even though there is considerable potential for this approach to reduce deaths from cancer.
A fourth obstacle to reducing cancer mortality is unequal access to cancer care. This translates into unequal access to cures. For example, the place of residence has a profound effect on the type of cancer care available. The country in which one lives and the type of medical plan available to citizens can determine what type of cancer care is available. Locally, living in an urban or rural area also influences the options for diagnosis and treatment. In the United States of America, economic status also profoundly affects what type of cancer care one receives and consequently the outcome of the disease.
Another obstacle is limited resources. The present era of great opportunity and progress in cancer research is continually challenged by lack of funding for both research and for dissemination of new findings. There is also a shortage of new treatments available to certain types of patients, in spite of promising new leads from research on targeted therapy. Shortages of critical personnel are also problematic. These range from nurses and technical staff to physicians and scientists who can bridge the gap between the laboratory and the delivery of cancer care. Several analyses predict that there will be a dire shortage of medical oncologists in the United States of America in the next few decades. The goal for the future must be to overcome these obstacles so that we make significant and substantive progress against this disease.
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